Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Gallbladder and Bile Duct Disorders, and Pediatric Hepatobiliary Diseases and Treatments.
Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study.
Biochemical Response Criteria Predict Transplant-Free Survival Across Disease Stages in Primary Biliary Cholangitis:Findings From the FiOCA Study
Sex Hormones and the Liver: Implications for Disease Progression and Hormonal Therapy.
Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial
In-Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment.
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world
Prevalence of Celiac Disease in Patients With Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study.
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
Primary Sclerosing Cholangitis: Diagnostic Criteria
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis
Liver transplantation for Wilson disease: Current knowledge and future perspectives.
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis.
Longer transplant-free and liver-related event-free survival in obeticholic acid-treated patients with primary biliary cholangitis compared to external controls from two large real-world cohorts
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one‐year non‐responders and predicts survival
Patient-reported quality of care in primary sclerosing cholangitis.
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight.
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.